916176-61-9 Usage
Uses
Used in Pharmaceutical Industry:
6-Fluoropyridine-2-boronic acid serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of novel drug candidates with improved properties, such as enhanced bioavailability, selectivity, and potency.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 6-Fluoropyridine-2-boronic acid is utilized for the design and synthesis of new molecules with potential therapeutic applications. The presence of the boronic acid group enables the compound to inhibit specific enzymes and receptors, which can be leveraged to develop drugs targeting various diseases.
Used in Drug Discovery:
6-Fluoropyridine-2-boronic acid plays a vital role in drug discovery, where it is employed to create new chemical entities with potential therapeutic effects. The incorporation of the fluorine atom can impart unique properties to the molecule, such as increased metabolic stability and lipophilicity, which are essential for the development of effective drug candidates.
Overall, 6-Fluoropyridine-2-boronic acid is a versatile and valuable chemical intermediate with significant applications in the pharmaceutical and related industries, contributing to the advancement of novel drug development and the improvement of existing therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 916176-61-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,1,7 and 6 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 916176-61:
(8*9)+(7*1)+(6*6)+(5*1)+(4*7)+(3*6)+(2*6)+(1*1)=179
179 % 10 = 9
So 916176-61-9 is a valid CAS Registry Number.
916176-61-9Relevant articles and documents
PYRROLOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASE
-
Page/Page column 95-96, (2010/11/25)
The present invention relates to compounds of formula (I) wherein Q, Z, R1 , R2 , and R3 are as described in claim 1 useful as inhibitors of protein kinases, particularly of JAK family and ROCK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
